The availability over the past 2 decades of the azole antifungal agents represents a major advance in management of systemic fungal infections. Like miconazol, fluconazole itraconazlole. These drugs having some drawbacks like interaction with co administered drugs, emergence of resistance of fungal organisms. From the limitations of therapeutically available benzimidazole containing antifungal agents and previous experiences of our department, we have synthesized different substituted aryl piperazines, 5-chloro-1-methyl-2-[α-(chloro) piperazin-1-yl ethyl benzimidazole nucleuses and condensed them to offer targeted compounds. Compounds were characterized by IR, 1H NMR. All the compounds were tested for their antifungal activity against fungal strain of Candida albicans. Most of the compounds showed moderate to good anti-fungal activity
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report